Results 11 to 20 of about 186,303 (292)

Mitral valve interventions in heart failure [PDF]

ESC Heart Failure, 2018
AbstractSecondary mitral regurgitation (MR) results from left ventricular dilatation and dysfunction. Quantification of secondary MR is challenging because of the underlying myocardial disease. Clinical and echocardiographic evaluation requires a multi‐parametric approach.
Ulrich Laufs, D Lavall, Stephan H. Schirmer, Andreas Hagendorff, Michael A. Borger, Michael Böhm   +5 more
openaire   +3 more sources

Mitral valve repair in heart failure [PDF]

European Journal of Heart Failure, 2000
AbstractMitral regurgitation (MR) is a frequent complication of end‐stage heart failure. Historically, these patients were either managed medically or with mitral valve replacement, both associated with poor outcomes. Mitral valve repair via an ‘undersized’ annuloplasty repair is safe and effectively corrects MR in heart‐failure patients.
Smolens, Iva A., Pagani, Francis D., Bolling, Steven F.   +2 more
openaire   +4 more sources

Mitral valve opening in the ovine heart [PDF]

American Journal of Physiology-Heart and Circulatory Physiology, 1998
To study the three-dimensional size, shape, and motion of the mitral leaflets and annulus, we surgically attached radiopaque markers to sites on the mitral annulus and leaflets in seven sheep. After 8 days of recovery, the animals were sedated, and three-dimensional marker positions were measured by computer analysis of biplane videofluorograms (60/s).
Terrence Tye, Julie R. Glasson, Neil B. Ingels, Masashi Komeda, Matts Karlsson, Matts Karlsson, D. Craig Miller, George T. Daughters, Ann F. Bolger, Linda E. Foppiano   +9 more
openaire   +3 more sources

Multidisciplinary decision-making in mitral valve disease: the mitral valve heart team [PDF]

Netherlands Heart Journal, 2019
Although decision-making using the heart-team approach is apparently intuitive and has a class I recommendation in most recent guidelines, supportive data is still lacking. The current study aims to demonstrate the individualised clinical pathway for mitral valve disease patients and to evaluate the outcome of all patients referred to the dedicated ...
Samuel Heuts, Samuel Heuts, Sem M. M. Hermans, P. Segers, S. A. F. Streukens, Jos G. Maessen, Jos G. Maessen, P. Sardari Nia, P. Sardari Nia, Emile C. Cheriex, Jindrich Vainer, Jules R. Olsthoorn   +11 more
openaire   +3 more sources

Pseudo-double orifice mitral valve or heart in heart mitral valve

Journal of Indian College of Cardiology, 2016
Abstract Pseudo-double orifice mitral valve is a condition characterised by double orifice appearance of mitral valve and it occurs as a result of acquired heart disease. This article describes echocardiographic appearance of this condition and helps in differentiating from double orifice mitral valve.
Arunkumar Panneerselvam, Rajesh Thilagam
openaire   +2 more sources

Combined mitral valve repair and heart transplantation [PDF]

Clinical Case Reports, 2018
Key Clinical MessageIn times of donor organ shortage, organs with extended allocation criteria, for example, valve pathologies, have to be taken into consideration for transplantation. The donor pool can be extended to hearts with mitral valve insufficiency.
Anke Sprengel, Wojtek Skwara, Tibor Ziegelhöffer, Ayse Cetinkaya, Markus Schönburg, Manfred Richter   +5 more
openaire   +2 more sources

Collagen composition of normal and myxomatous human mitral heart valves.

Biochemical Journal, 1984
The collagens were studied in 13 normal and 19 myxomatous human mitral valves. The collagens of the valve were completely solubilized by using a method consisting of guanidinium chloride extraction, limited pepsin digestions and CNBr cleavage of the ...
William G. Cole, Danny Chan, J. Andrew, HICKEYt, David E. L. WILCKENt   +4 more
semanticscholar   +1 more source

Tissue Heart Valve Replacement at BSMMU- Initial Experience with Two Cases

Bangabandhu Sheikh Mujib Medical University Journal, 2010
Research on prosthesis to replace diseased heart valves began almost simultaneously with mechanical valves which are durable but with inherent thromboembolic complication requiring life-long anticoagulant therapy and tissue valves which are more prone to
Rezwanul Hoque, Mostafa Nuruzzaman, Sabrina Sharmeen Husain, Md Anwarul Islam, Magfur Rahman, Md Aftabuddin   +5 more
doaj   +1 more source

Rheumatic Heart Disease and Myxomatous Degeneration: Differences and Similarities of Valve Damage Resulting from Autoimmune Reactions and Matrix Disorganization. [PDF]

PLoS ONE, 2017
Autoimmune inflammatory reactions leading to rheumatic fever (RF) and rheumatic heart disease (RHD) result from untreated Streptococcus pyogenes throat infections in individuals who exhibit genetic susceptibility.
Carlo de Oliveira Martins, Lea Demarchi, Frederico Moraes Ferreira, Pablo Maria Alberto Pomerantzeff, Carlos Brandao, Roney Orismar Sampaio, Guilherme Sobreira Spina, Jorge Kalil, Edecio Cunha-Neto, Luiza Guilherme   +9 more
doaj   +1 more source

Dabigatran versus warfarin in patients with mechanical heart valves.

New England Journal of Medicine, 2013
BACKGROUND Dabigatran is an oral direct thrombin inhibitor that has been shown to be an effective alternative to warfarin in patients with atrial fibrillation. We evaluated the use of dabigatran in patients with mechanical heart valves. METHODS In this
J. Eikelboom, S. Connolly, M. Brueckmann, C. Granger, A. Kappetein, M. Mack, Jon Blatchford, Kevin Devenny, J. Friedman, K. Guiver, Ruth Harper, Y. Khder, M. Lobmeyer, H. Maas, J. Voigt, M. Simoons, F. Van de Werf   +16 more
semanticscholar   +1 more source